ABSTRACT
La infección fúngica peritoneal es poco frecuente pero supone una elevada mortalidad. A pesar de que la principal recomendación es la retirada de catéter cuando se sospecha que es éste el foco de infección, hay ocasiones en las se requiere considerar otras opciones. La administración de anidulafungina intraperitoneal es una técnica sobre la que hay pocos estudios. Presentamos un caso clínico en el que administramos anidulafungina intraperitoneal y analizamos mediante técnica cualitativa la presencia del antifúngico en distintas muestras. Además, calculamos el porcentaje de reducción de anidulafungina entre el líquido de diálisis en el que la diluimos y este mismo tras permanecer 8 horas en la cavidad peritoneal. (AU)
Peritoneal fungal infection is rare but involves high mortality. Although the main recommendation is catheter removal when it is suspected that this is the focus of infection, there are occasions when other options are required.There are few references about administration of intraperitoneal anidulafungin. We present a clinical case in which we administer intraperitoneal anidulafungin and analyze the presence of this antifungal in different samples using a qualitative technique. In addition, we calculate the percentage reduction of anidulafungin between the dialysis fluid in which we diluted it and this fluid after remain 8 hours in the peritoneal cavity. (AU)
Subject(s)
Humans , Female , Aged , Anidulafungin/analysis , 25783/adverse effects , Candida glabrataSubject(s)
Anti-HIV Agents/adverse effects , Desensitization, Immunologic , HIV Protease Inhibitors/therapeutic use , Pyridines/therapeutic use , Pyrones/therapeutic use , Stevens-Johnson Syndrome/etiology , Darunavir , Drug Resistance, Multiple, Viral , Enfuvirtide , HIV Envelope Protein gp41 , HIV Infections/drug therapy , HIV Protease Inhibitors/administration & dosage , HIV Protease Inhibitors/adverse effects , Humans , Lamivudine/administration & dosage , Lamivudine/therapeutic use , Male , Middle Aged , Peptide Fragments , Pyridines/administration & dosage , Pyridines/adverse effects , Pyrones/administration & dosage , Pyrones/adverse effects , Pyrrolidinones/adverse effects , Raltegravir Potassium , Recurrence , Ritonavir/administration & dosage , Ritonavir/therapeutic use , Stevens-Johnson Syndrome/prevention & control , Sulfonamides/adverse effectsABSTRACT
No disponible
Subject(s)
Humans , Male , Infant , Nerium/poisoning , Plant Poisoning/diagnosis , Gastric Lavage , ImmunoassayABSTRACT
No disponible
